Who owns NKGEN BIOTECH INC?
- Ticker: NKGN
- CUSIP Number: 65488a101
Tip: Access positions for across all investors
Analyze quarterly positions in Nkgen Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nkgen Biotech stock
Who bought or sold NKGEN BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Meteora Capital | 1.2M | $2.3M | 100% | Mar 2024 |
|
| Polar Securities | 1.1M | $2.0M | 0% | Mar 2024 |
|
| University Of Chicago | 550k | $1.0M | 0% | Mar 2024 |
|
| Vanguard Group | 54k | $102k | 100% | Mar 2024 |
|
| Geode Capital Management | 53k | $101k | 100% | Mar 2024 |
|
| Susquehanna International | 17k | $32k | 100% | Mar 2024 |
|
| Sequoia Financial Advisors | 16k | $30k | 100% | Mar 2024 |
|
| Northern Trust | 16k | $30k | 100% | Mar 2024 |
|
| UBS Group | 11k | $21k | 100% | Mar 2024 |
|
| Towneley Capital Management, Inc / DE | 10k | $19k | 100% | Mar 2024 |
|
| Tower Research Capital | 3.8k | $7.2k | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 500.00 | $945.000000 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 48.00 | $90.998400 | 2% | Mar 2024 |
|
Who sold out of Nkgen Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sandia Investment Management | Dec 2023 | 443k | $4.6M |
| Millennium Management | Dec 2023 | 18k | $51k |